Sandhill Capital Partners LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Sandhill Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.63 - $0.96 $31,500 - $48,000	-50,000 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$0.92 - $1.22 $18,400 - $24,400	-20,000 Reduced 28.57%	50,000 $50,000
Q3 2021 Nov 12, 2021	BUY	$0.67 - $1.51 $26,800 - $60,400	40,000 Added 133.33%	70,000 $91,000
Q2 2021 Aug 11, 2021	BUY	$0.75 - $1.1 $7,500 - $11,000	10,000 Added 50.0%	30,000 $23,000
Q1 2021 May 13, 2021	BUY	$0.96 - $1.74 $9,600 - $17,400	10,000 Added 100.0%	20,000 $21,000
Q4 2020 Feb 12, 2021	BUY	$0.76 - $1.47 $7,600 - $14,700	10,000 New	10,000 $14,000

33M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $115M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Sandhill Capital Partners LLC with notifications on news.